Graham Doyle

Stock Analyst at UBS

(1.07)
# 3,862
Out of 5,073 analysts
404
Total ratings
48.4%
Success rate
-1.1%
Average return

Stocks Rated by Graham Doyle

Fresenius Medical Care AG
Oct 20, 2026
Reiterated: Sell
Price Target: €36.00
Current: €38.45
Upside: -6.37%
Fresenius SE & Co. KGaA
Sep 17, 2026
Reiterated: Buy
Price Target: €56.00
Current: €45.60
Upside: +22.82%
Straumann Holding AG
Sep 1, 2026
Upgraded: Buy
Price Target: CHF 90.00 → CHF 115.00
Current: CHF 95.60
Upside: +20.29%
Smith & Nephew plc
Aug 25, 2026
Reiterated: Hold
Price Target: 1,300p → 1,120p
Current: 1,089p
Upside: +2.89%
Ottobock SE & Co. KGaA
Aug 24, 2026
Reiterated: Buy
Price Target: €74.00 → €78.00
Current: €50.40
Upside: +54.76%
Alcon Inc.
Aug 14, 2026
Reiterated: Buy
Price Target: CHF 86.00 → CHF 83.00
Current: CHF 55.92
Upside: +48.43%
Carl Zeiss Meditec AG
Aug 11, 2026
Downgraded: Sell
Price Target: €25.00 → €22.60
Current: €34.22
Upside: -33.96%
Convatec Group PLC
Aug 6, 2026
Reiterated: Buy
Price Target: 375p
Current: 240p
Upside: +56.25%
Siemens Healthineers AG
Aug 3, 2026
Reiterated: Hold
Price Target: €38.00
Current: €41.71
Upside: -8.89%
Koninklijke Philips N.V.
Aug 3, 2026
Downgraded: Hold
Price Target: €32.50 → €24.00
Current: €23.41
Upside: +2.52%
Rated: Hold
Price Target: $67 → $73
Current: $69.01
Upside: +5.78%
Reiterated: Hold
Price Target: CHF 151.00 → CHF 148.00
Current: CHF 116.20
Upside: +27.37%
Downgraded: Sell
Price Target: kr 39.00
Current: kr 55.90
Upside: -30.23%
Reiterated: Hold
Price Target: CHF 215.00
Current: CHF 276.80
Upside: -22.33%
Downgraded: Hold
Price Target: n/a
Current: $126.88
Upside: n/a
Reiterated: Buy
Price Target: n/a
Current: $12,614.00
Upside: n/a
Reiterated: Hold
Price Target: n/a
Current: $1,868.00
Upside: n/a
Reiterated: Buy
Price Target: €90.00
Current: €44.63
Upside: n/a
Downgraded: Hold
Price Target: CHF 275.00
Current: CHF 392.00
Upside: n/a